Therapeutic potential of targeting protein for Xklp2 silencing for pancreatic cancer

Publisher： John Wiley & Sons Inc

E-ISSN： 2045-7634|4|7|1091-1100

ISSN： 2045-7634

Source： Cancer Medicine, Vol.4, Iss.7, 2015-07, pp. : 1091-1100

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic potential of targeting ceramide/glucosylceramide pathway in cancer

By Kartal Yandım Melis   Apohan Elif   Baran Yusuf  

Cancer Chemotherapy and Pharmacology, Vol. 71, Iss. 1, 2013-01 ,pp. : 13-20

Springer Publishing Company

Access to resources Recommend Favorite

Target protein for Xklp2 (TPX2), a microtubule-related protein, contributes to malignant phenotype in bladder carcinoma

By Yan Liang   Li Shenglei   Xu Changbao   Zhao Xinghua   Hao Bin   Li Huixiang   Qiao Baoping  

Tumor Biology, Vol. 34, Iss. 6, 2013-12 ,pp. : 4089-4100

Springer Publishing Company

Access to resources Recommend Favorite

Targeting mTOR: Evaluating the Therapeutic Potential of Resveratrol for Cancer Treatment

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 13, Iss. 7, 2013-09 ,pp. : 1032-1038

Bentham Science Publishers

Access to resources Recommend Favorite

Ribozyme targeting of HER-2 inhibits pancreatic cancer cell growth in vivo

By Thybusch-Bernhardt A.   Aigner A.   Beckmann S.   Czubayko F.   Juhl H.  

European Journal of Cancer, Vol. 37, Iss. 13, 2001-09 ,pp. : 1688-1694

Elsevier

Access to resources Recommend Favorite

Optimizing Gene Silencing Strategies for Pancreatic Cancer

By  

Current Cancer Therapy Reviews, Vol. 9, Iss. 2, 2013-05 ,pp. : 117-125

Bentham Science Publishers

Access to resources Recommend Favorite